Superdisintegrants Market

Superdisintegrants Market Size (2022 to 2027)

As per our research report, the size of the global superdisintegrants market is projected to reach USD 358.4 Million in 2022. This value is estimated to be growing at a CAGR of 7.8% during the forecast period and worth USD Million 521.75 by 2027.

Superdisintegrants are one of the many kinds of excipients utilized in the pharmaceutical industry for tablet-based drug administration. Disintegrants are substances that expand and dissolve when wet causing the tablet to break apart in the digestive tract, releasing active ingredients for absorption. They make sure that when the tablet is in contact with water, it breaks down rapidly into smaller fragments, making way for dissolution, thus reducing the time required for the drug release.

MARKET DRIVERS:

Increasing healthcare expenditure and healthcare awareness among individuals have accounted for the growth of the global superdisintegrants market.

The growth of the Superdisintegrants market is further attributed to factors like the growing population of geriatric and pediatric patients, the growing generic drugs market, and the development of new Superdisintegrants in the pharmaceutical industry. Increasing demand for manufacturing highly accurate and useful drugs with appropriate dosage levels of various excipients and active ingredients elevates the market's need. A rise in healthcare expenditure and growing disposable income in urban areas is straightly lavishing the growth of the market.

The main goal of the drug manufacturers is to reduce the dissolving time of a tablet in the digestive part and release active ingredients, which is solely to set up growth opportunities for the market. The growing prevalence of producing generic drugs is also fueling the growth of the market. Rising incidences of chronic diseases and other health disorders due to lifestyle changes and food habits create chances for the market to grow eventually.

MARKET RESTRAINTS:

However, the growth of the market is hindered by the declining financial support for R&D fields. Although synthetic Superdisintegrants have been the standard for many decades now, more significant research into natural Superdisintegrants will motivate the future growth of the global superdisintegrants market.

Impact of Covid-19 on the global superdisintegrants Market:

The COVID-19 pandemic had disrupted the global economy. It is due to the commercial and industrial zones have been put under lockdown by government bodies. However, if no more lockdowns are enforced across the world, the economy is expected to rebound quickly and return to pre-COVID levels by the end of 2021. Pharmaceutical and biotech companies, in collaboration with governments around the world, are working to combat the COVID-19 epidemic, from vaccine production to prepare for challenges in the pharmaceutical supply chain.

Besides that, widely used medications like Hydroxychloroquine have seen a large rise in demand for the treatment of COVID-19. Since many developing countries are low on these medications, the high demand has presented a tremendous opportunity for manufacturers of COVID-19 control drugs. Superdisintegrants are agents added to tablets to speed up the tablet's breakdown into small fragments in aqueous conditions, allowing the substance to be released more quickly into the body. The global effects of the COVID-19 pandemic are already being felt, and the superdisintegrants market will be greatly impacted in 2020. Superdisintegrants have gained the attention of the pharmaceutical industry in recent years because they improve the solubility of active pharmaceutical ingredients (API) in the body by increasing drug absorption, thus increasing drug bioavailability. Tablets and capsules contain the super disintegrant agent. The market for superdisintegrants has been steadily growing in recent years, and it is expected to continue growing during the forecast period.

REPORT COVERAGE:

This research report on the global superdisintegrants market has been segmented and sub-segmented based on the product type, application, therapeutic area & region.

Superdisintegrants Market – By Product Type: 

• Natural Superdisintegrants
• Synthetic Superdisintegrants
  • Modified Starch
  • Crospovidone
  • Modified Cellulose
  • Ion Exchange Resins
  • Calcium Silicates
• Others

Based on product type, Natural super disintegrants have the highest growth rate from the past decade. Increasing prevalence for the organic raw materials to manufacture various drugs which configure lower side effects is prompting the demand of the market. 

Superdisintegrants Market – By Application:

• Capsules
• Tablets

Based on the application, the Capsules category is witnessed in holding the highest shares of the market. The increasing production rate of the drugs to meet the end-users requirements is escalating the growth of the superdisintegrants market.

Superdisintegrants Market – By Therapeutic Area:

• Gastrointestinal diseases
• Neurological diseases
• Oncology
• Infectious Diseases
• Cardiovascular Diseases
• Hematological diseases
• Inflammatory Diseases

Based on the therapeutic area, the Gastrointestinal diseases area is leading to dominant shares of the market. Growing popularity towards over-the-counter drugs is a common factor for the market to grow extensively. Also, the rise in the support from the private and public organizations through investments mainly to improve the quality of treatment procedures is leveraging the market's demand.

Superdisintegrants Market – By Region:

• North America
• Europe
• Asia-Pacific
• Latin America
• The Middle East and Africa

Geographically, the North American region is leading the global market while Europe is in second place. Increasing financial support for the development of innovative oral dosage forms and constant effort devoted to providing superior quality and compliant products in the market are the primary factors responsible for the dominance of North America and Europe.

The Asia Pacific is expected to grow the fastest due to increasing healthcare spending, rising healthcare infrastructure and awareness, and growing outsourcing of excipient manufacturing to Asian countries like India and China. The synthetic superdisintegrants market segment held the largest share of the global superdisintegrants market.

It is mainly accounted for the prevalent use of excipients such as sodium starch glycolate and crospovidone in orally and fast disintegrating tablets. Rising incidences of cardiovascular diseases, neurological diseases, and other related diseases are further expected to drive the demand for fast disintegrating tablets, driving the market of Superdisintegrants during the forecast period.

KEY MARKET PLAYERS:

Notable companies dominating the global superdisintegrants market are Ashland, BASF SE, FMC Corporation, JRS Pharma, DFE Pharma, Roquette, The Dow Chemical Company, Asahi Kasei Corporation, Nippon Soda Co, Huber Corporation.

RECENT MARKET DEVELOPMENTS:

• In October 2019, Roquette opened a new Pharmaceutical Research and Development (R&D) and Customer Technical Service (CTS) facility in Biopolis, Singapore, for the development of new drugs and applications for existing products and preclinical research.
• In March 2017, BASF Group launched the Innovation Campus, Asia Pacific, in India, marking its largest R&D investment in the country. To expand its global and regional research activities, the organization invested USD 61.6 million (EUR 50 million) in this center.
• In October 2016, Ashland opened a new pharmaceutical excipient facility in Nanjing, China. Through this facility, the company offers highly functional excipient technologies to manufacturers of oral pharmaceuticals, as well as custom formulation solutions.
• In June 2016, DuPont established its ASEAN (Association of Southeast Asian Nations) headquarters in Singapore to strengthen its competitive position in major growth markets.
• In March 2016, Roquette was awarded the EXCiPACT certification for Good Industrial Practices, including the manufacturing, testing, and packaging of a range of excipients.